Vertex Pharmaceuticals Raises FY2026 Sales Guidance from $13.100B-$13.200B to $13.150B-$13.250B vs $13.245B Est
Benzinga Newsdesk 1 day ago
NewsGuidanceHot
Vertex Pharmaceuticals (NASDAQ:VRTX) raises FY2026 sales outlook from $13.100 billion-$13.200 billion to $13.150 billion-$13.250 billion vs $13.245 billion estimate.
Vertex Pharmaceuticals (NASDAQ:VRTX) raises FY2026 sales outlook from $13.100 billion-$13.200 billion to $13.150 billion-$13.250 billion vs $13.245 billion estimate.